Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medbright AI Investments Inc C.MBAI

Alternate Symbol(s):  MBAIF

MedBright AI Investments Inc. is a capital allocator focused on investing in healthcare technology companies. The Company is engaged in constructing a portfolio of synergistic investments to generate returns for shareholders. The Company is focused on significant near-term and midterm opportunities with potential returns while maintaining a commitment to governance. It is focused on investing in technology and artificial intelligence companies, combined with healthcare operators.


CSE:MBAI - Post by User

Post by 1StockInformeron Mar 14, 2024 8:21pm
38 Views
Post# 35933983

MBAI Partners w/ Dermatology Institute & Skin Care Center

MBAI Partners w/ Dermatology Institute & Skin Care Center

In a groundbreaking move towards revolutionizing outpatient facility management, MedBright AI Investments Inc. (CSE:MBAI, OTCQB:MBAIF) unveiled its cutting-edge AI platform, MedMatrix. The MedMatrix platform harnesses the power of artificial intelligence to optimize clinic operations, streamline expansion efforts, and maximize revenue potential for healthcare facilities.


Through a strategic partnership with Dermatology Institute & Skin Care Center (DISCC), MedBright is demonstrating the tangible impact of its innovative technology in shaping the future of healthcare operations. DISCC, leveraging the MedMatrix AI Market Expander, is embarking on a journey to strategically expand its clinic locations in Southern California. 


Dr. Paul Yamauchi, MD, PhD, highlights the significance of this collaboration, emphasizing the invaluable role of MedMatrix in swiftly identifying optimal clinic locations. By simulating various scenarios and meticulously analyzing critical factors like patient demographics and market competition, DISCC aims to streamline its expansion efforts, ensuring alignment with patient needs while maximizing revenue potential.


Trevor Vieweg, CEO of MedBright, expresses confidence in the MedMatrix suite's ability to drive operational excellence for DISCC. As DISCC continues to leverage MedMatrix Reporter and Market Expander to refine its expansion strategy, MedBright reaffirms its commitment to providing unparalleled support and ushering in a new era of efficiency in healthcare management.


MedBright's transition from the beta phase to full commercialization marks a significant milestone in the company's journey. With an impressive roster of 14 prestigious clinics, including affiliations with institutions like Yale School of Medicine, onboarded within a mere two months, MedMatrix has garnered substantial industry interest. 


The comprehensive suite of AI-driven features promises to revolutionize clinic operations, with projected revenue increases of up to 10% without additional expenditures.


The MedMatrix suite comprises five core features, each designed to address specific pain points and optimize clinic performance:


AI Reporter: Empowering clinics with comprehensive data reporting and forecasting capabilities for operational optimization.

AI Market Expander: Facilitating informed expansion decisions through in-depth analysis of patient demographics, market competition, and facility costs.

AI Resource Matcher: Enhancing clinic efficiency by optimizing appointment scheduling based on patient needs and resource availability.

AI Claim Optimizer: Streamlining revenue cycle management by identifying coding inaccuracies and optimizing claim processing.

AI Revenue Enhancer: Unlocking untapped revenue opportunities within existing patient bases, maximizing profitability for clinics.


With the beta phase concluded, MedMatrix stands poised for full commercialization and the deal with DISCC is yet another example of the rapid scalability of this AI technology.


Full News: https://financialpost.com/globe-newswire/southern-california-clinic-uses-medmatrix-ai-market-expander-to-launch-opening-of-new-clinic-locations


Posted on behalf of MedBright AI Investments Inc.

 
<< Previous
Bullboard Posts
Next >>